The potential association between a new angiogenic marker fractalkine and a placental vascularization in preeclampsia
© 2021. The Author(s)..
PURPOSE: Impaired angiogenesis is one of the most common findings in preeclamptic placentas. A new angiogenetic role of fractalkine (CX3CL1) is recently recognized apart from inflammatory activity. In this study, a link between CX3CL1 and the development of placental vasculature in preeclampsia was examined.
METHODS: The study comprised 52 women allocated to Group 1 (normotensive, n = 23) and Group 2 (preeclampsia, n = 29). In each group Doppler parameters, serum levels of CX3CL1, soluble fms-like tyrosine kinase-1 (sFlt-1), and placental growth factor (PlGF) were assessed between 30 and 32 week of pregnancy. After the delivery, placental samples were taken and the vascularization and expression of CX3CR1 receptor were assessed after immunostaining.
RESULTS: CX3CL1 and sFlt-1 serum levels were significantly higher levels in Group 2 vs Group 1, while PlGF serum levels was significantly lower in Group 2. Lower cerebroplacental ratio (CPR) was observed in Group 2. The vascular/extravascular tissue index (V/EVTI) was significantly lower in Group 2, while compared to Group 1, with the lowest value in the fetus growth restriction (FGR) subgroup (0.18 ± 0.02; 0.24 ± 0.03; 0.16 ± 0.02, respectively). The expression of examined CX3CR1 was higher in Group 2, while compared to Group 1, reaching the highest values in FGR subgroup. There was a moderate negative correlation between birth weight, V/EVTI and CX3CL1 serum level and CX3CR1 placental expression in the group of pregnancies complicated with preeclampsia.
CONCLUSION: The significant underdevelopment of placental vascular network in preeclampsia is associated with the change in the CX3CL1/CX3CR1 system, especially in FGR complicated pregnancies.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:304 |
---|---|
Enthalten in: |
Archives of gynecology and obstetrics - 304(2021), 2 vom: 26. Aug., Seite 365-376 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Szewczyk, Grzegorz [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 28.10.2021 Date Revised 28.10.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1007/s00404-021-05966-3 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM320587983 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM320587983 | ||
003 | DE-627 | ||
005 | 20231225173913.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s00404-021-05966-3 |2 doi | |
028 | 5 | 2 | |a pubmed24n1068.xml |
035 | |a (DE-627)NLM320587983 | ||
035 | |a (NLM)33496844 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Szewczyk, Grzegorz |e verfasserin |4 aut | |
245 | 1 | 4 | |a The potential association between a new angiogenic marker fractalkine and a placental vascularization in preeclampsia |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 28.10.2021 | ||
500 | |a Date Revised 28.10.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2021. The Author(s). | ||
520 | |a PURPOSE: Impaired angiogenesis is one of the most common findings in preeclamptic placentas. A new angiogenetic role of fractalkine (CX3CL1) is recently recognized apart from inflammatory activity. In this study, a link between CX3CL1 and the development of placental vasculature in preeclampsia was examined | ||
520 | |a METHODS: The study comprised 52 women allocated to Group 1 (normotensive, n = 23) and Group 2 (preeclampsia, n = 29). In each group Doppler parameters, serum levels of CX3CL1, soluble fms-like tyrosine kinase-1 (sFlt-1), and placental growth factor (PlGF) were assessed between 30 and 32 week of pregnancy. After the delivery, placental samples were taken and the vascularization and expression of CX3CR1 receptor were assessed after immunostaining | ||
520 | |a RESULTS: CX3CL1 and sFlt-1 serum levels were significantly higher levels in Group 2 vs Group 1, while PlGF serum levels was significantly lower in Group 2. Lower cerebroplacental ratio (CPR) was observed in Group 2. The vascular/extravascular tissue index (V/EVTI) was significantly lower in Group 2, while compared to Group 1, with the lowest value in the fetus growth restriction (FGR) subgroup (0.18 ± 0.02; 0.24 ± 0.03; 0.16 ± 0.02, respectively). The expression of examined CX3CR1 was higher in Group 2, while compared to Group 1, reaching the highest values in FGR subgroup. There was a moderate negative correlation between birth weight, V/EVTI and CX3CL1 serum level and CX3CR1 placental expression in the group of pregnancies complicated with preeclampsia | ||
520 | |a CONCLUSION: The significant underdevelopment of placental vascular network in preeclampsia is associated with the change in the CX3CL1/CX3CR1 system, especially in FGR complicated pregnancies | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Observational Study | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Angiogenesis | |
650 | 4 | |a Fractalkine | |
650 | 4 | |a Placenta | |
650 | 4 | |a Preeclampsia | |
650 | 7 | |a Biomarkers |2 NLM | |
650 | 7 | |a CX3C Chemokine Receptor 1 |2 NLM | |
650 | 7 | |a CX3CR1 protein, human |2 NLM | |
650 | 7 | |a Chemokine CX3CL1 |2 NLM | |
650 | 7 | |a Placenta Growth Factor |2 NLM | |
650 | 7 | |a 144589-93-5 |2 NLM | |
650 | 7 | |a FLT1 protein, human |2 NLM | |
650 | 7 | |a EC 2.7.10.1 |2 NLM | |
650 | 7 | |a Vascular Endothelial Growth Factor Receptor-1 |2 NLM | |
650 | 7 | |a EC 2.7.10.1 |2 NLM | |
700 | 1 | |a Pyzlak, Michał |e verfasserin |4 aut | |
700 | 1 | |a Pankiewicz, Katarzyna |e verfasserin |4 aut | |
700 | 1 | |a Szczerba, Ewa |e verfasserin |4 aut | |
700 | 1 | |a Stangret, Aleksandra |e verfasserin |4 aut | |
700 | 1 | |a Szukiewicz, Dariusz |e verfasserin |4 aut | |
700 | 1 | |a Skoda, Marta |e verfasserin |4 aut | |
700 | 1 | |a Bierła, Joanna |e verfasserin |4 aut | |
700 | 1 | |a Cukrowska, Bożena |e verfasserin |4 aut | |
700 | 1 | |a Fijałkowska, Anna |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Archives of gynecology and obstetrics |d 1995 |g 304(2021), 2 vom: 26. Aug., Seite 365-376 |w (DE-627)NLM012938351 |x 1432-0711 |7 nnns |
773 | 1 | 8 | |g volume:304 |g year:2021 |g number:2 |g day:26 |g month:08 |g pages:365-376 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00404-021-05966-3 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 304 |j 2021 |e 2 |b 26 |c 08 |h 365-376 |